Clinical trial
Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome
NCT01887119 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Aldosterone Antagonism on Insulin-mediated Microvascular Function in Subjects With the Metabolic Syndrome
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 31, 2013
- Completion date
- November 30, 2018
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal obesity metabolic syndrome, hypertension, insulin resistance